Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Risk Factors Associated With Unplanned Acute Care in Outpatient Chemotherapy With Oral Anticancer Drugs as Monotherapy or Combination Therapy With Injectable Anticancer Drugs

KENJI KAWASUMI, YOHEI KAWANO, AZUSA KUJIRAI, YASUNARI MANO, REIKO MATSUI, AYAKO MAEDA-MINAMI, YUICHIRO YAMAMOTO, KENICHI NEGISHI, SHUJI SHIMADA, MASAKAZU YAMAGUCHI, MASASHI NAGATA and TAKAO AOYAMA
Anticancer Research November 2021, 41 (11) 5827-5834; DOI: https://doi.org/10.21873/anticanres.15401
KENJI KAWASUMI
1Faculty of Pharmaceutical Sciences, Tokyo University of Science (TUS), Chiba, Japan;
2Department of Pharmacy, National Cancer Center Hospital East (NCCHE), Chiba, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOHEI KAWANO
1Faculty of Pharmaceutical Sciences, Tokyo University of Science (TUS), Chiba, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: yohei-kawano@rs.tus.ac.jp
AZUSA KUJIRAI
1Faculty of Pharmaceutical Sciences, Tokyo University of Science (TUS), Chiba, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YASUNARI MANO
1Faculty of Pharmaceutical Sciences, Tokyo University of Science (TUS), Chiba, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
REIKO MATSUI
2Department of Pharmacy, National Cancer Center Hospital East (NCCHE), Chiba, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AYAKO MAEDA-MINAMI
1Faculty of Pharmaceutical Sciences, Tokyo University of Science (TUS), Chiba, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUICHIRO YAMAMOTO
1Faculty of Pharmaceutical Sciences, Tokyo University of Science (TUS), Chiba, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KENICHI NEGISHI
1Faculty of Pharmaceutical Sciences, Tokyo University of Science (TUS), Chiba, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHUJI SHIMADA
1Faculty of Pharmaceutical Sciences, Tokyo University of Science (TUS), Chiba, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASAKAZU YAMAGUCHI
3Department of Pharmacy, National Cancer Center Hospital (NCCH), Tokyo, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASASHI NAGATA
4Department of Pharmacy, Medical Hospital, Tokyo Medical and Dental University (TMDU), Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKAO AOYAMA
1Faculty of Pharmaceutical Sciences, Tokyo University of Science (TUS), Chiba, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles
PreviousNext
Back to top

In this issue

Anticancer Research: 41 (11)
Anticancer Research
Vol. 41, Issue 11
November 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Risk Factors Associated With Unplanned Acute Care in Outpatient Chemotherapy With Oral Anticancer Drugs as Monotherapy or Combination Therapy With Injectable Anticancer Drugs
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 12 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Risk Factors Associated With Unplanned Acute Care in Outpatient Chemotherapy With Oral Anticancer Drugs as Monotherapy or Combination Therapy With Injectable Anticancer Drugs
KENJI KAWASUMI, YOHEI KAWANO, AZUSA KUJIRAI, YASUNARI MANO, REIKO MATSUI, AYAKO MAEDA-MINAMI, YUICHIRO YAMAMOTO, KENICHI NEGISHI, SHUJI SHIMADA, MASAKAZU YAMAGUCHI, MASASHI NAGATA, TAKAO AOYAMA
Anticancer Research Nov 2021, 41 (11) 5827-5834; DOI: 10.21873/anticanres.15401

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Risk Factors Associated With Unplanned Acute Care in Outpatient Chemotherapy With Oral Anticancer Drugs as Monotherapy or Combination Therapy With Injectable Anticancer Drugs
KENJI KAWASUMI, YOHEI KAWANO, AZUSA KUJIRAI, YASUNARI MANO, REIKO MATSUI, AYAKO MAEDA-MINAMI, YUICHIRO YAMAMOTO, KENICHI NEGISHI, SHUJI SHIMADA, MASAKAZU YAMAGUCHI, MASASHI NAGATA, TAKAO AOYAMA
Anticancer Research Nov 2021, 41 (11) 5827-5834; DOI: 10.21873/anticanres.15401
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The Systemic Inflammation Score Is an Independent Prognostic Factor for Esophageal Cancer Patients who Receive Curative Treatment
  • Impact of Cytoreductive Nephrectomy Following Nivolumab Plus Ipilimumab Therapy for Patients With Advanced Renal Cell Carcinoma
  • Usefulness of Prophylactic Administration of Pegfilgrastim for Esophageal Cancer Chemotherapy: A Single-center Retrospective Study
Show more Clinical Studies

Similar Articles

Keywords

  • Oral anticancer drug
  • chemotherapy-related unplanned acute care
  • chemotherapy-related hospitalisation
  • chemotherapy-related consultation
  • outpatient cancer chemotherapy
  • case-control study
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire